找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Health Economics from Theory to Practice; Optimally Informing Simon Eckermann Book 2017 Springer International Publishing AG 2017 Cost Eff

[复制链接]
楼主: invigorating
发表于 2025-3-23 13:38:06 | 显示全部楼层
ns.Principles and methods are illustrated across health prom.This book provides a robust set of health economic principles and methods to inform societal decisions in relation to research, reimbursement and regulation (pricing and monitoring of performance in practice). We provide a theoretical and
发表于 2025-3-23 17:26:45 | 显示全部楼层
发表于 2025-3-23 18:35:23 | 显示全部楼层
发表于 2025-3-24 01:32:47 | 显示全部楼层
发表于 2025-3-24 06:24:22 | 显示全部楼层
The Health Shadow Price and Economically Meaningful Threshold Valuesl to all decision making across joint research, reimbursement and regulatory decisions in practice. The health shadow price in doing so addresses research and reimbursement (adoption and displacement) biases against better use of existing technology and towards new technology that underlie many current health-system inefficiencies.
发表于 2025-3-24 07:06:46 | 显示全部楼层
发表于 2025-3-24 10:52:05 | 显示全部楼层
发表于 2025-3-24 18:05:40 | 显示全部楼层
Principles and Practice for Trial-Based Health Economic Analysisand illustrated. Principles are introduced considering the decision analytic basis for comparing alternate strategies in defined patient populations and their costs and effects along treatment pathways. Decision analytic principles for robust cost effectiveness analysis are shown to require joint co
发表于 2025-3-24 21:23:01 | 显示全部楼层
Avoiding Frankenstein’s Monster and Partial Analysis Problems: Robustly Synthesising, Translating anmental to allowing unbiased trial-based cost effectiveness analysis for two-strategy comparisons. In this chapter, we extend these principles to identify methods for robust cost effectiveness analysis relevant to decision making in any given jurisdiction of interest (e.g. Australia with a PBAC remit
发表于 2025-3-24 23:22:45 | 显示全部楼层
The Value of Value of Information Methods to Decision-Making: What VOI Measures Enable Optimising Jol net benefit in Fig. 5.2, what is the expected value of additional information? Given costs of obtaining additional evidence or information, is it worth undertaking further research or not? If it is optimal to undertake further research, how much research is optimal?
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-12 08:59
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表